Literature DB >> 25983869

Nephrotic syndrome and chronic kidney disease in a young African patient from Saint Thomas and Prince: what is the link?

Sara Gonçalves1, José António Lopes1, Paulo Fernandes1, Fernando Abreu1, Alice Fortes1, José Barbas1, Maria João Palhano2, Mateus Martins Prata1.   

Abstract

Entities:  

Keywords:  African patient; chronic kidney disease; nephrotic syndrome

Year:  2008        PMID: 25983869      PMCID: PMC4421165          DOI: 10.1093/ndtplus/sfn003

Source DB:  PubMed          Journal:  NDT Plus        ISSN: 1753-0784


× No keyword cloud information.
A 17-year-old black African female from Saint Thomas and Prince with growth failure and a 5-year history of frothy urine and periorbitary oedema was referred to our department for evaluation of renal insufficiency. At admission, the patient was hypertensive and malnourished, and presented with jugular engorgement, pulmonary rales, liver enlarged to 9 cm below the right costal margin and lower leg oedema. Laboratory tests revealed ferropenic anaemia (haemoglobin: 7.4 g/dL; ferritin 24.2 ng/mL, transferrin saturation 4%), eosinophilia (10.5%), renal dysfunction (urea 280 mg/dL, creatinine 7.0 mg/dL), hypoalbuminaemia (2.8 g/dL) and hyperfibrinogenaemia (550 mg/dL). Transaminases and C-reactive protein were on the normal range, and there was no hyperlipidaemia. Urinalysis showed proteinuria (>300 mg/dL) and haematuria (80 erythrocytes/μL), and daily protein excretion was 3.5 g/1.73 m2. Ultrasonography revealed normal renal size and increased cortical echogenicity of the kidneys, hepatosplenomegaly and celiac adenopathies. Chest X-ray revealed cardiomegaly, and ecocardiography showed dilation of left ventricle, low ejection fraction (<10%) and restrictive diastolic filling pattern. The patient started haemodialysis. Further studies were negative for dysproteinaemias, vasculitis, systemic lupus erythematosous and viral infections, including human immunodeficiency virus infection, hepatitis B and hepatitis C. Evaluation of Plasmodium infection and tuberculosis was also negative.

Question

What is your diagnosis?

Answer to the quiz

The patient was affected by AA amyloidosis secondary to chronic schistosomiasis. A subcutaneous abdominal fat biopsy was performed and it was positive for amyloid, as shown by Congo red staining with green birefringence under polarized light; type AA was identified by immunohistochemistry (Figure 1). Taking into consideration this diagnosis and the patient's origin, other parasitary infections were evaluated by searching for eggs, cysts and parasites in stools and urine, and by serology. Despite other parasitary infections being excluded, the immunoenzimatic assay (1/10 240) and the immunoblot were both positive for Schistosoma. To investigate active infection, a rectal biopsy was then performed and showed viable Schistosoma mansoni ova (Figure 2); thus, the patient was treated with pranziquantel (40 mg/kg/day) for 2 days. The patient was discharged in a stable condition, but she remained dialysis dependent.
Fig. 1

Deposits of type AA amyloid in subcutaneous abdominal fat (immunohistochemistry).

Fig. 2

Viable Schistosoma mansoni egg (rectal biopsy).

Deposits of type AA amyloid in subcutaneous abdominal fat (immunohistochemistry). Viable Schistosoma mansoni egg (rectal biopsy). Schistosomiasis was firstly described by Theodor Bilharz in 1852 and it is caused by infection with parasitic blood flukes known as schistosomes. There are three major species (S mansoni, S japonicum and S haematobium) that produce infection in humans, and tend to occur in restricted geographic patterns; for example, Schistosoma mansoni is more prevalent in sub-Saharan Africa, the Middle East, South America and the Caribbean. In the endemic areas, the infection is usually acquired in childhood and the chronic complications (intestinal, hepatic, urinary neurologic and pulmonary) are more common [1,2]. Various glomerulopathies (mesangioproliferative, diffuse proliferative, membranoproliferative, focal segmental glomerulosclerosis, amyloid and cryoglobulinemic) have been described in patients with Schistosomiasis, and Schistosoma mansoni accounts for the most clinically significant cases [3,4]. Amyloidosis is the predominant lesion in <5% of patients with clinically overt schistosomal glomerulopathy, and hepatosplenomegaly, nephrotic syndrome and renal failure are the most common clinical findings [3,4]. Our case highlights that Schistosomiasis must always be considered in the differential diagnosis of the nephrotic syndrome and chronic kidney disease in patients from endemic areas for this infection. Conflict of interest statement. None declared.
  4 in total

1.  The changing face of schistosomal glomerulopathy.

Authors:  Rashad Barsoum
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

Review 2.  Schistosomal glomerulopathies.

Authors:  R S Barsoum
Journal:  Kidney Int       Date:  1993-07       Impact factor: 10.612

Review 3.  Human schistosomiasis.

Authors:  Bruno Gryseels; Katja Polman; Jan Clerinx; Luc Kestens
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

Review 4.  Schistosomiasis.

Authors:  D R Lucey; J H Maguire
Journal:  Infect Dis Clin North Am       Date:  1993-09       Impact factor: 5.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.